Annual FCF
-$7.33 M
+$5.22 M+41.60%
December 31, 2023
Summary
- As of February 12, 2025, ENTX annual free cash flow is -$7.33 million, with the most recent change of +$5.22 million (+41.60%) on December 31, 2023.
- During the last 3 years, ENTX annual FCF has risen by +$3.28 million (+30.94%).
- ENTX annual FCF is now -130.19% below its all-time high of -$3.18 million, reached on December 31, 2016.
Performance
ENTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$2.15 M
-$819.00 K-61.35%
September 30, 2024
Summary
- As of February 12, 2025, ENTX quarterly free cash flow is -$2.15 million, with the most recent change of -$819.00 thousand (-61.35%) on September 30, 2024.
- Over the past year, ENTX quarterly FCF has dropped by -$292.00 thousand (-15.68%).
- ENTX quarterly FCF is now -61.35% below its all-time high of -$1.33 million, reached on June 30, 2024.
Performance
ENTX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$7.97 M
-$629.00 K-8.56%
September 30, 2024
Summary
- As of February 12, 2025, ENTX TTM free cash flow is -$7.97 million, with the most recent change of -$629.00 thousand (-8.56%) on September 30, 2024.
- Over the past year, ENTX TTM FCF has dropped by -$404.00 thousand (-5.34%).
- ENTX TTM FCF is now -217.14% below its all-time high of -$2.51 million, reached on March 31, 2018.
Performance
ENTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ENTX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +41.6% | -15.7% | -5.3% |
| 3 y3 years | +30.9% | -38.1% | +1.1% |
| 5 y5 years | +25.7% | -38.1% | +1.1% |
ENTX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +41.6% | -61.4% | +55.3% | -18.7% | +38.9% |
| 5 y | 5-year | at high | +41.6% | -61.4% | +55.3% | -18.7% | +38.9% |
| alltime | all time | -130.2% | +41.6% | -61.4% | +55.3% | -217.1% | +38.9% |
Entera Bio Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.15 M(+61.3%) | -$7.97 M(+8.6%) |
| Jun 2024 | - | -$1.33 M(-28.3%) | -$7.34 M(-3.0%) |
| Mar 2024 | - | -$1.86 M(-29.0%) | -$7.57 M(+3.3%) |
| Dec 2023 | -$7.33 M(-41.6%) | -$2.62 M(+71.9%) | -$7.33 M(+9.0%) |
| Sep 2023 | - | -$1.52 M(-2.2%) | -$6.72 M(-16.7%) |
| Jun 2023 | - | -$1.56 M(-3.7%) | -$8.06 M(-13.8%) |
| Mar 2023 | - | -$1.62 M(-19.6%) | -$9.35 M(-25.5%) |
| Dec 2022 | -$12.55 M(+38.2%) | -$2.01 M(-29.9%) | -$12.55 M(-3.9%) |
| Sep 2022 | - | -$2.87 M(+0.9%) | -$13.05 M(+6.1%) |
| Jun 2022 | - | -$2.85 M(-40.9%) | -$12.30 M(+6.3%) |
| Mar 2022 | - | -$4.82 M(+90.9%) | -$11.57 M(+27.5%) |
| Dec 2021 | -$9.08 M(-14.4%) | -$2.52 M(+19.2%) | -$9.08 M(+12.3%) |
| Sep 2021 | - | -$2.12 M(-0.2%) | -$8.09 M(-8.5%) |
| Jun 2021 | - | -$2.12 M(-8.6%) | -$8.84 M(-13.7%) |
| Mar 2021 | - | -$2.32 M(+51.8%) | -$10.25 M(-3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$10.61 M(+18.4%) | -$1.53 M(-46.7%) | -$10.61 M(-13.6%) |
| Sep 2020 | - | -$2.87 M(-18.6%) | -$12.29 M(+10.9%) |
| Jun 2020 | - | -$3.53 M(+31.3%) | -$11.08 M(+14.4%) |
| Mar 2020 | - | -$2.69 M(-16.2%) | -$9.68 M(+8.0%) |
| Dec 2019 | -$8.96 M(-9.2%) | -$3.20 M(+92.9%) | -$8.96 M(+10.5%) |
| Sep 2019 | - | -$1.66 M(-21.9%) | -$8.11 M(-6.6%) |
| Jun 2019 | - | -$2.13 M(+8.2%) | -$8.68 M(-6.8%) |
| Mar 2019 | - | -$1.97 M(-16.4%) | -$9.32 M(-5.6%) |
| Dec 2018 | -$9.86 M(+115.5%) | -$2.35 M(+5.1%) | -$9.86 M(+31.3%) |
| Sep 2018 | - | -$2.24 M(-19.0%) | -$7.51 M(+42.4%) |
| Jun 2018 | - | -$2.76 M(+9.8%) | -$5.28 M(+109.8%) |
| Mar 2018 | - | -$2.51 M | -$2.51 M |
| Dec 2017 | -$4.58 M(+43.8%) | - | - |
| Dec 2016 | -$3.18 M(-10.3%) | - | - |
| Dec 2015 | -$3.55 M | - | - |
FAQ
- What is Entera Bio annual free cash flow?
- What is the all time high annual FCF for Entera Bio?
- What is Entera Bio annual FCF year-on-year change?
- What is Entera Bio quarterly free cash flow?
- What is the all time high quarterly FCF for Entera Bio?
- What is Entera Bio quarterly FCF year-on-year change?
- What is Entera Bio TTM free cash flow?
- What is the all time high TTM FCF for Entera Bio?
- What is Entera Bio TTM FCF year-on-year change?
What is Entera Bio annual free cash flow?
The current annual FCF of ENTX is -$7.33 M
What is the all time high annual FCF for Entera Bio?
Entera Bio all-time high annual free cash flow is -$3.18 M
What is Entera Bio annual FCF year-on-year change?
Over the past year, ENTX annual free cash flow has changed by +$5.22 M (+41.60%)
What is Entera Bio quarterly free cash flow?
The current quarterly FCF of ENTX is -$2.15 M
What is the all time high quarterly FCF for Entera Bio?
Entera Bio all-time high quarterly free cash flow is -$1.33 M
What is Entera Bio quarterly FCF year-on-year change?
Over the past year, ENTX quarterly free cash flow has changed by -$292.00 K (-15.68%)
What is Entera Bio TTM free cash flow?
The current TTM FCF of ENTX is -$7.97 M
What is the all time high TTM FCF for Entera Bio?
Entera Bio all-time high TTM free cash flow is -$2.51 M
What is Entera Bio TTM FCF year-on-year change?
Over the past year, ENTX TTM free cash flow has changed by -$404.00 K (-5.34%)